{
  "case_id": "case_0005",
  "provider": "goog",
  "status": "processed",
  "patient_demographics": {
    "age": 41.05,
    "sex": "Female",
    "genderIdentity": "Cisgender Male",
    "ancestry": "Sub-Saharan African"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\nAgree with lesions involving:\n- left optic nerve (cranial nerve II) and right cerebellum.",
      "structured_data": {
        "gt_lesions_english": [
          "right cerebellum",
          "left optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "Optic Nerve",
            "side": "left",
            "qualifier": null
          },
          {
            "location": "Cerebellar Hemisphere",
            "side": "right",
            "qualifier": null
          }
        ],
        "exact_matches": [
          "left optic nerve (cranial nerve II)",
          "right cerebellum"
        ],
        "imprecise_matches": [],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 2,
        "imprecisely_identified_count": 0,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 1.0,
        "proportion_imprecise": 0.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included: Multiple sclerosis\n  \nThese suggested differentials are reasonable:\n\n- Neuromyelitis Optica Spectrum Disorder; MOG Antibody Disease; Neurosarcoidosis",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Multiple Sclerosis",
          "Neuromyelitis Optica Spectrum Disorder",
          "MOG Antibody Disease",
          "Neurosarcoidosis"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation",
          "Pelvic pain": "comorbidity",
          "Nightmares": "comorbidity",
          "Hypercholesterolaemia": "comorbidity",
          "Rosacea": "comorbidity",
          "Fibroids": "comorbidity"
        },
        "correctly_mentioned": [
          "Multiple sclerosis"
        ],
        "missing_diagnoses": [
          "Pelvic pain",
          "Nightmares",
          "Hypercholesterolaemia",
          "Rosacea",
          "Fibroids"
        ],
        "additional_diagnoses": [
          "Neuromyelitis Optica Spectrum Disorder",
          "MOG Antibody Disease",
          "Neurosarcoidosis"
        ]
      },
      "scoring": {
        "ms_included": 1,
        "incidental_total_count": 0,
        "incidental_missing_count": 0,
        "incidental_missing_proportion": null,
        "comorbidity_total_count": 0,
        "comorbidity_missing_count": 0,
        "comorbidity_missing_proportion": null
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\nAgree with all suggestions.\n\n- MRI including the Brain and Orbits and CSF test for Oligoclonal Bands would potentially inform a diagnosis of multiple sclerosis.",
      "structured_data": {
        "gt_required_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI of Brain, Orbits, and full Spine with gadolinium contrast",
          "Aquaporin-4 (AQP4) Antibody Test",
          "Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Test",
          "Lumbar Puncture for CSF analysis (including cell count, protein, glucose, oligoclonal bands, and IgG index)",
          "Full Blood Count",
          "Erythrocyte Sedimentation Rate",
          "C-Reactive Protein",
          "Antinuclear Antibody",
          "Angiotensin-Converting Enzyme",
          "Vitamin B12",
          "Syphilis Serology",
          "HIV Serology",
          "Visual Evoked Potentials"
        ],
        "found_tests": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests": []
      },
      "scoring": {
        "gt_tests_count": 3,
        "found_tests_count": 3,
        "missing_tests_count": 0,
        "proportion_found": 1.0,
        "proportion_missing": 0.0
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint is not specified, so no indication whether this is related to MS.\n\n- Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "High-Dose Intravenous Corticosteroids",
            "timing": "Start Now",
            "reasons": [
              "To reduce the severity and duration of the acute disabling relapse.",
              "The patient has functionally significant deficits including optic neuritis and cerebellar ataxia."
            ]
          },
          {
            "treatment": "Disease-Modifying Therapy (DMT) for Multiple Sclerosis",
            "timing": "Delay",
            "reasons": [
              "A definitive diagnosis must be established and key mimics (NMOSD, MOGAD) must be excluded via serology first.",
              "Choice of DMT depends on full investigation results and a shared decision-making process with the patient."
            ]
          },
          {
            "treatment": "Physiotherapy and Occupational Therapy",
            "timing": "Start Now",
            "reasons": [
              "To address the significant gait and limb ataxia.",
              "To improve safety, prevent falls, and maximise functional recovery during and after the acute relapse."
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "High-Dose Intravenous Corticosteroids",
            "timing": "Start Now",
            "reasons": [
              "To reduce the severity and duration of the acute disabling relapse.",
              "The patient has functionally significant deficits including optic neuritis and cerebellar ataxia."
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Presenting complaint is not specified, so no indication whether this is related to MS.",
                "Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Unsafe decision to start treatment now.\n  \nAdditional factors not mentioned:\n\n- Presenting complaint is not specified, so no indication whether this is related to MS.\n\n- Timing of current symptoms not specified, so no indication whether this is a recent issue or old deficit.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Disease-Modifying Therapy (DMT) for Multiple Sclerosis",
            "timing": "Delay",
            "reasons": [
              "A definitive diagnosis must be established and key mimics (NMOSD, MOGAD) must be excluded via serology first.",
              "Choice of DMT depends on full investigation results and a shared decision-making process with the patient."
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Safety screen for contraindications like active infection is required before immunosuppression.",
                "Need a pregnancy test result.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate decision to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Safety screen for contraindications like active infection is required before immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        }
      },
      "scoring": {
        "steroids": {
          "decision_safety": 1,
          "gt_reasons_count": 4,
          "acknowledged_reasons_count": 0,
          "missed_reasons_count": 4,
          "proportion_reasons_acknowledged": 0.0,
          "proportion_reasons_missed": 1.0
        },
        "dmt": {
          "decision_safety": 0,
          "gt_reasons_count": 4,
          "acknowledged_reasons_count": 2,
          "missed_reasons_count": 2,
          "proportion_reasons_acknowledged": 0.5,
          "proportion_reasons_missed": 0.5
        }
      }
    }
  }
}